Perforation of small intestinal metastasis of lung adenocarcinoma treated with pembrolizumab: a case report

BACKGROUND: Pembrolizumab is an immune checkpoint inhibitor and is an anti-human programmed cell death-1 (PD-1) monoclonal antibody. Pembrolizumab is used for non-small cell lung carcinoma with high programmed cell death ligand-1 (PD-L1) expression. It has been found that better overall survival can...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Shoki, Senmaru, Naoto, Ishido, Keita, Saito, Takahiro, Poudel, Saseem, Muto, Jun, Syouji, Yasuhito, Hase, Ryunosuke, Hirano, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821905/
https://www.ncbi.nlm.nih.gov/pubmed/31667679
http://dx.doi.org/10.1186/s40792-019-0730-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821905/
https://www.ncbi.nlm.nih.gov/pubmed/31667679
http://dx.doi.org/10.1186/s40792-019-0730-6

Ejemplares similares